Nathan Alidina

Nathan Alidina is an experienced professional in the biotechnology and clinical research fields, currently serving as a Manufacturing Associate III at AGC Biologics since August 2020. In this role, Nathan leads a team in the manufacture of the Novavax COVID-19 vaccine, managing daily activities and writing training materials. Prior to this, Nathan worked as a COVID Clinical Trial Technician at the University of Washington, contributing to multiple COVID-19 clinical trials. Previous positions include Senior Research Scientist at Pluristyx, Inc., Process Engineer 2 at Universal Cells, and Cellular Processing Technician 2 at Fred Hutch, with responsibilities spanning stem cell research, process development, and cellular therapy manufacturing. Nathan began a career in research at the Benaroya Research Institute and Seattle Biomedical Research Institute, focusing on diabetes and malaria studies, respectively. Nathan holds a Bachelor of Science in Chemistry from the University of Washington, obtained in 1999.